How Big Pharma monetised depression

For the past 35 years, “awareness” of depression and other mental health issues has led to a dramatic rise in prescribing antidepressants – and increasing diagnoses of depression. There is a reason why: the chasm between what is told to the public and what is found in the scientific literature, Robert Whitaker explains in UnHerd.